Search
  • Jill Forrest, President Oncology Strategies

Top 20 Drugs of 2018 from Fierce Pharma


"Check out the list below, and you'll notice several major blockbusters benefiting from biosimilar delays. You'll also see some small-molecule meds that are about to fall hard to generic competition. Overall, the assortment of drugs spans specialty fields such as cancer and immunology, and mass-market indications such as diabetes." Fierce Pharma

Click on either image to go to article...


38 views

info@oncologystrategies.com   |   Overland Park, KS 66223

  • Facebook Basic Black
  • Twitter Basic Black
  • Black Instagram Icon